Brief: Usana Health Sciences - Enters First Amendment To Credit Agreement On Sept 30, 2026 - SEC Filing
BRIEF-Usana Health Sciences - Enters First Amendment To Credit Agreement On Sept 30, 2026 - SEC Filing Oct 5 (Reuters) - USANA Health Sciences Inc USNA.N:
USANA HEALTH SCIENCES - ENTERS FIRST AMENDMENT TO CREDIT AGREEMENT ON SEPT 30, 2026 - SEC FILING
USANA HEALTH SCIENCES - CREDIT AGREEMENT PROVIDES $75 MILLION REVOLVER, MAY INCREASE TO $200 MILLION, MATURING JUNE 27, 2030 - SEC FILING
USANA HEALTH SCIENCES - AMENDMENT REQUIRES MINIMUM CONSOLIDATED EBITDA OF $100 MILLION FOR TRAILING FOUR-FISCAL-QUARTER PERIOD STARTING Q4 2026
USANA HEALTH SCIENCES - MINIMUM CONSOLIDATED EBITDA DROPS TO $70 MILLION IF REVOLVING EXPOSURE IS $50 MILLION OR LESS - SEC FILING
USANA HEALTH SCIENCES - AUSTRALIA PTY, PERMITTED TO SELL SYDNEY PROPERTY AND APPLY NET PROCEEDS - SEC FILING
Source text: [ID:n0000896264-26-000060]
Further company coverage: USNA.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on USANA Health Sciences
See all newsBrief: Usana Schedules Third Quarter 2026 Earnings Release And Conference Call
Brief: Usana Health Sciences - Enters First Amendment To Credit Agreement On Sept 30, 2026 - SEC Filing
USANA Health Sciences Q2 sales fall amid weaker Hiya and Rise performance
Brief: USANA Health Sciences Q2 EPS USD -1.16
Usana Health Sciences Inc Expected To Post Earnings Of 43 Cents A Share: Earnings Preview